Sb Investment Advisers (Uk) LTD Vir Biotechnology, Inc. Transaction History
Sb Investment Advisers (Uk) LTD
- $10.1 Billion
- Q1 2024
A detailed history of Sb Investment Advisers (Uk) LTD transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Sb Investment Advisers (Uk) LTD holds 16,684,041 shares of VIR stock, worth $148 Million. This represents 1.67% of its overall portfolio holdings.
Number of Shares
16,684,041
Previous 16,684,041
-0.0%
Holding current value
$148 Million
Previous $168 Million
0.7%
% of portfolio
1.67%
Previous 1.5%
Shares
6 transactions
Others Institutions Holding VIR
# of Institutions
225Shares Held
88.2MCall Options Held
177KPut Options Held
182K-
Black Rock Inc. New York, NY16.6MShares$147 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$110 Million0.0% of portfolio
-
State Street Corp Boston, MA7.07MShares$62.9 Million0.0% of portfolio
-
Baillie Gifford & CO3.95MShares$35.1 Million0.03% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.41MShares$30.3 Million0.01% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.18B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...